Study Stopped
Slow enrolment
Effect of Establishing Functional Residual Capacity During Newborn Resuscitation on Oxygenation
Effects of Oxygen and Functional Residual Capacity on the Oxygen Saturations of Infants ≥ 35 Weeks Gestation During Delivery Room Resuscitation.
1 other identifier
interventional
40
1 country
1
Brief Summary
Currently, newborns receive 100% supplemental oxygen by free flow when they remain cyanotic despite demonstrating regular respiratory effort. Resuscitating infants with continuous positive airway pressure (CPAP) in room air may improve oxygen saturations more quickly than providing FFO2 because of its ability to establish functional residual capacity in the lungs. Our primary hypothesis is that in this blinded, randomized control trial, more infants (≥35 weeks gestation) resuscitated with CPAP in room air will have an oxygen saturation ≥80% at five minutes of age compared to infants resuscitated with the 50% FFO2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2007
CompletedFirst Posted
Study publicly available on registry
September 18, 2007
CompletedStudy Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedOctober 12, 2016
October 1, 2016
2 years
September 17, 2007
October 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure is the proportion of infants achieving a stable oxygen saturation of ≥80%. To be considered stable, the oxygen saturation must remain at or above the predetermined target saturation for at least 30 seconds.
5 minutes after birth
Secondary Outcomes (1)
The secondary outcome measure is the proportion of infants achieving a stable oxygen saturation of ≥90%.
10 minutes after birth
Study Arms (2)
1
EXPERIMENTALResuscitation will proceed as per standard of care and infants are only to receive respiratory support if they remain cyanotic despite 60 seconds of spontaneous regular respirations. All infants will have a pulse oximetry probe placed on the right hand (pre-ductal position) immediately after birth. Infants that meet the entry criteria will be randomized to resuscitation with one of two neonatal T-piece resuscitator circuits: GROUP 1 - infants will receive CPAP of 6 cm H2O with 21% oxygen continuously for at least 5 minutes.
2
ACTIVE COMPARATORResuscitation will proceed as per standard of care and infants are only to receive respiratory support if they remain cyanotic despite 60 seconds of spontaneous regular respirations. Infants that meet the entry criteria will be randomized to resuscitation with one of two neonatal T-piece resuscitator circuits: GROUP 2 - infants will receive 50% oxygen at a rate of 6 liters per minute continuously for at least 5 minutes using a modified neonatal T-piece resuscitator circuit that does not generate pressure. Fifty percent oxygen was chosen because it reflects the actual inspired oxygen concentration when 100% oxygen is blown towards the infant's face.
Interventions
Infants will receive CPAP of 6 cm H2O with 21% oxygen continuously for at least 5 minutes
Infants will receive 50% oxygen delivered by a modified neonatal T-piece resuscitator circuit that does not generate pressure for at least 5 minutes.
Eligibility Criteria
You may qualify if:
- Inborn
- ≥35 weeks gestational age
- Neonatal resuscitation team present at delivery
- Central cyanosis despite 60 seconds of spontaneous respirations in room air. Sustained respirations are defined as: spontaneous breathing that is regular in rhythm and sufficient to maintain a heart rate ≥100 beats per minute such that provision of artificial tidal volume breathing is not required.
You may not qualify if:
- Lethal anomalies
- Cyanotic congenital heart disease
- Known hemoglobinopathy
- Risk of persistent pulmonary hypertension (eg, meconium aspiration, conditions associated with pulmonary hypoplasia such as prolonged)
- Known anatomical lung abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- American Academy of Pediatricscollaborator
Study Sites (1)
Foothills Hospital
Calgary, Alberta, T2N 2T9, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yacov Rabi, MD, FRCPC
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 17, 2007
First Posted
September 18, 2007
Study Start
February 1, 2008
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
October 12, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share